Tyrosine Kinase

Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A4237 Amuvatinib (MP-470, HPK 56)Summary: Tyrosine kinase inhibitor -
A2974 Foretinib (GSK1363089)1 CitationSummary: VEGF and HGF receptor inhibitor -
A2689 ButeinTarget: Src|STAT|EGFR|Angiotensin-Converting Enzymes (ACEs)|5-Lipoxygenases|PTK|enoyl-acyl-carrier protein reductaseSummary: Protein kinase inhibitor -
A8324 LDN-1931898 CitationTarget: BMP and Other Activin ReceptorsSummary: ALK inhibitor,potent and selective -
A8548 Fingolimod (FTY720)Target: S1P receptorsSummary: S1P receptors agonist -
A8604 GNF 5Target: Bcr-AblSummary: Bcr-Abl inhibitor -
B5621 Y 11Summary: focal adhesion kinase (FAK) inhibitor -
B5659 GSK2578215ASummary: LRRK2 inhibitor -
B3553 GS-9973Target: SykSummary: Syk inhibitor, orally bioavailable and selective -
B7808 NT1571 CitationSummary: IRS-1/2 inhibitor, inhibits IGF-1R and STAT3 signaling pathway
